Company attributes
Location
Founder
Full Address
888 SEVENTH AVENUE 12TH FLOOR NEW YORK, NY 101060
Founded Date
2000
CFO
Country
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Aisling Capital is a venture capital and private equity firm investing in healthcare and biotechnology companies that is headquartered in New York City, New York and was founded in 2000.
Investments
The firms invests primarily in companies commercializing healthcare products, services, and technologies. Aisling Capital has raised about $1.8 billion in committed capital across 4 investment funds and has made 106 investments. Notable investments made by the firm include: Dermira, BridgeBio, Atreca, TransEnterix, ViewRay, T2 Biosystems, Arcus Biosciences, Aimmune Therapeutics, Eidos Therapeutics, and Avrobio.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
